Soluventis Nanotherapeutics Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Private

  • Employees
  • 8

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 1

Soluventis Nanotherapeutics General Information

Description

Developer of oligonucleotide therapeutics designed to transport therapeutic nucleic acids and peptides. The company's therapeutics help in transporting the active substances from the blood and the immune system and reaching reliable target organs, including poorly vascularized tumor tissue, enabling clinicians to reduce tumor bulges in a shorter period.

Contact Information

Formerly Known As
Management Partner MPuls GmbH Unternehmensberater, AMS Action Multiplier Systems GmbH Management Partner Unternehmensberater
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 136 Universitätsstr.
  • 44799 Bochum
  • Germany
+49 0234
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Vertical(s)
Corporate Office
  • 136 Universitätsstr.
  • 44799 Bochum
  • Germany
+49 0234

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Soluventis Nanotherapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Secondary Transaction - Private 16-Jan-2026 Completed Generating Revenue
3. Seed Round 01-Jan-2019 Completed Generating Revenue
2. Seed Round 01-Jan-2018 $500K $500K Completed Generating Revenue
1. Seed Round 01-Feb-2011 Completed Generating Revenue
To view Soluventis Nanotherapeutics’s complete valuation and funding history, request access »

Soluventis Nanotherapeutics Patents

Soluventis Nanotherapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
DE-202024103258-U1 Anti-glare protection Active 17-Jun-2024
DE-102020133903-A1 Sensor device and method for detecting the presence of media using a sensor device Pending 17-Dec-2020
WO-2022127996-A1 Sensor device and method for detecting the presence of media using a sensor device Inactive 17-Dec-2020
EP-3052625-A1 Notch 1 specific sirna molecule Active 30-Sep-2013
JP-2019196384-A Notch 1 specific sirna molecule Active 30-Sep-2013 C12N15/1138
To view Soluventis Nanotherapeutics’s complete patent history, request access »

Soluventis Nanotherapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Soluventis Nanotherapeutics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Global Source Ventures Venture Capital Minority
To view Soluventis Nanotherapeutics’s complete investors history, request access »

Soluventis Nanotherapeutics FAQs

  • When was Soluventis Nanotherapeutics founded?

    Soluventis Nanotherapeutics was founded in 2009.

  • Where is Soluventis Nanotherapeutics headquartered?

    Soluventis Nanotherapeutics is headquartered in Bochum, Germany.

  • What is the size of Soluventis Nanotherapeutics?

    Soluventis Nanotherapeutics has 8 total employees.

  • What industry is Soluventis Nanotherapeutics in?

    Soluventis Nanotherapeutics’s primary industry is Drug Discovery.

  • Is Soluventis Nanotherapeutics a private or public company?

    Soluventis Nanotherapeutics is a Private company.

  • What is Soluventis Nanotherapeutics’s current revenue?

    The current revenue for Soluventis Nanotherapeutics is .

  • How much funding has Soluventis Nanotherapeutics raised over time?

    Soluventis Nanotherapeutics has raised $900K.

  • Who are Soluventis Nanotherapeutics’s investors?

    Global Source Ventures has invested in Soluventis Nanotherapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process